University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

NCI-Supported Programs

Multidisciplinary programs include laboratory scientists, clinical investigators, providers of patient care, epidemiologists, and sociobehavioral scientists. Collaboration across disciplines ensures that insights gained in the lab can move quickly and effectively to cancer patients' bedsides and to cancer prevention and control programs. The following multidisciplinary research programs are supported by the National Cancer Institute Cancer Center Support Grant.

Breast Oncology Program

Breast Oncology

The goal of the Breast Oncology Program is to support and stimulate basic, clinical, and population research in breast cancer and to facilitate the translation of these findings into improved cancer management and control.
Cancer Control Program

Cancer Control

The Cancer Control Program focuses on social, behavioral, communications, and health policy research, integrating it with cancer research across the spectrum from the basic to the population sciences.
Cancer Genetics Program

Cancer Genetics

The goal of the Cancer Genetics Program is to elucidate the genetics of tumor susceptibility, tumorigenesis, and progression, and to use this information clinically to improve cancer management.
Cancer Immunology Program

Cancer Immunology

The Cancer Immunology Program supports research revealing insights into the interactions between evolving neoplastic cells with activated non-neoplastic host cells, and with soluble or insoluble components of extracellular matrix, as well as studies based on these interactions that foster development of novel cellular or molecular-based strategies to combat cancer.
Experimental Therapeutics Program

Experimental Therapeutics

The Experimental Therapeutics Program brings together basic cancer biologists and physician scientists to discover and test novel compounds and treatment strategies for cancer.
Hematopoietic Malignancies Program

Hematopoietic Malignancies

The Hematopoietic Malignancies Program aims to develop more effective and less toxic therapeutics for hematopoietic cancers; investigate the genetic and environmental causes of hematologic cancers; and educate trainees, health care professionals, patients, and the public about leukemia, lymphoma, and myeloma.
Neurologic Oncology Program

Neurologic Oncology

The Neurologic Oncology Program aims to impact the diagnosis and treatment of brain cancer using a team approach.
Pediatric Malignancies Program

Pediatric Malignancies

The goal of the Pediatric Malignancies Program is to improve the outcome for children with cancer by investigating links between normal development and the aberrant signaling networks of childhood malignancies, and to leverage these genetic networks to identify new therapeutic targets that we integrate into innovative clinical trials.
Prostate Cancer Program

Prostate Cancer

The Prostate Cancer Program promotes interdisciplinary research to support the development of novel management and intervention strategies to improve the lives of men with prostate cancer.
Tobacco Program

Tobacco Control

The goal of the Tobacco Control Program is to eradicate the use of tobacco and tobacco-induced cancer and other diseases worldwide.

Photos courtesy of the National Cancer Institute/ NCI Cancer Closeup Collection